Free release
rel-4-((3aR,4S,7R,7aS)-1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-

rel-4-((3aR,4S,7R,7aS)-1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-

CAS No. :1127442-82-3MDL No. :MFCD18086875Formula :C25H19N3O3Boiling Point :-Linear Structure Formula :-InChI Key :-M.W

Sales:Service@apichina.com
CAS No. :1127442-82-3 Brand :Qitai
Formula :C25H19N3O3 M.W :409.44

Introduction

CAS No. :1127442-82-3 MDL No. :MFCD18086875
Formula : C25H19N3O3 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 409.44 Pubchem ID :-
Synonyms :
IWR-1-endo;endo-IWR 1
Chemical Name :rel-4-((3aR,4S,7R,7aS)-1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-yl)benzamide

Physicochemical Properties

Num. heavy atoms : 31
Num. arom. heavy atoms : 16
Fraction Csp3 : 0.2
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 120.33
TPSA : 79.37 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.25
Log Po/w (XLOGP3) : 2.93
Log Po/w (WLOGP) : 3.23
Log Po/w (MLOGP) : 2.97
Log Po/w (SILICOS-IT) : 2.72
Consensus Log Po/w : 3.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.34
Solubility : 0.0186 mg/ml ; 0.0000455 mol/l
Class : Moderately soluble
Log S (Ali) : -4.26
Solubility : 0.0226 mg/ml ; 0.0000552 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.34
Solubility : 0.000185 mg/ml ; 0.000000452 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.01
Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram: